Ayrton Capital LLC 13D/13G Filings for Traws Pharma, Inc. (TRAW)

Ayrton Capital LLC 13D and 13G filings for Traws Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-13
1:07 pm
Purchase
2024-12-31 13G Traws Pharma, Inc.
TRAW
Ayrton Capital LLC 403,650
9.900%
403,650increase
(New Position)
Filing